Medicaid Drug Rebate Program Newly Reported Outpatient Drugs, November 2023

Newly reported, active covered outpatient drugs submitted by participating manufacturers to the Medicaid Drug Rebate Program (MDRP) database between November 13 and November 19, 2023. The data is provided by the U.S. Department of Health & Human Services and was last updated on the platform in March 2026. It likely contains product information for drugs added since the last quarterly update of the MDRP database.

Use Cases

• Track recent additions to Medicaid-covered drug formularies based on newly reported drug data
• Analyze manufacturer reporting patterns for outpatient drugs based on the quarterly update cycle
• Monitor the introduction of new active pharmaceutical products into a major public health program

Strengths

• Data originates from the authoritative U.S. Department of Health & Human Services.
• Covers a specific weekly reporting period (2023-11-13 to 2023-11-19) for temporal precision.
• Platform metadata indicates a recent update timestamp of 2026-03-25.

Limitations

• Row count and file size are unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by participating drug manufacturers to the Medicaid Drug Rebate Program (MDRP).

Time Range

2023-11-13 to 2023-11-19

Freshness

Data covers a specific week in November 2023; platform record was updated in March 2026.

Geography

United States